FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Macleods Pharma Eszopiclone Tablets Recall

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for…

Macleods Pharma Usa Inc · Plainsboro, NJ

Risk level
Class II
Reported by FDA
Jul 13, 2022
Recall ID
D-1174-2022
Check your lot numberHow we source this data

Summary

Macleods Pharma recalled Eszopiclone Tablets starting Jun 16, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1174-2022 on Jul 13, 2022. Reason: Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles. Status: Terminated.

Why it was recalled

Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.

Product description

Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07

Lot numbers, UPCs & expiration codes

Lot #: BEK2009A Exp: 11/2023

Where it was sold

Distributed Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1174-2022
Classification
Class II
Status
Terminated
Recall initiated
Jun 16, 2022
FDA report date
Jul 13, 2022
Quantity
168690 Tablets
Recall type
Voluntary: Firm initiated
Recalling firm
Macleods Pharma Usa Inc

Original FDA data

Every field from FDA enforcement report D-1174-2022, exactly as published.

Show all FDA fields
City
Plainsboro
State
NJ
Status
Terminated
Country
United States
Event ID
90444
Address
666 Plainsboro Rd Bldg 200 Ste 230
Code information
Lot #: BEK2009A Exp: 11/2023
Postal code
08536-0009
Report date
Jul 13, 2022
Product type
Drugs
Recall number
D-1174-2022
Classification
Class II
Recalling firm
Macleods Pharma Usa Inc
Product quantity
168690 Tablets
Termination date
Mar 20, 2024
Reason for recall
Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA, NDC 33342-299-07
Distribution pattern
Distributed Nationwide and Puerto Rico.
Recall initiation date
Jun 16, 2022
Initial firm notification
Letter
Center classification date
Jul 5, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1174-2022, published Jul 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls